Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ji Lin

Showing results (751-760 of 888) with videos related to

Pageof 89
Sort By:
Cancer Cell International|November 8, 2023
Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesisPei-Hua Peng, Ji-Lin Chen, Heng-Hsiung Wu, et al.
Chinese Medical Journal|March 28, 2008
Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stentBo Xu, Qi Zhang, Yue-jin Yang, et al.
Chinese Medical Journal|March 28, 2009
Long-term follow-up of crush versus no crush technique for coronary artery bifurcation lesionsZhan Gao, Yue-Jin Yang, Bo Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Phase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced CancerDavid Hong, Jeffrey Infante, Filip Janku, et al.
Chinese Medical Journal|February 4, 2006
Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteriesJi-lin Chen, Run-lin Gao, Yue-jin Yang, et al.
Coronary Artery Disease|October 17, 2008
Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stentJue Chen, Jian-Jun Li, Ji-Lin Chen, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|January 13, 2009
[Outcome of patients implanted with bioabsorbable polymer sirolimus-eluting stent (Excel) and the durable polymer sirolimus-eluting stent (Cypher)]Zhan GAO, Yue-jin YANG, Ji-lin CHEN, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2016
Exoplanet orbital eccentricities derived from LAMOST-Kepler analysisJi-Wei Xie, Subo Dong, Zhaohuan Zhu, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|August 23, 2007
[Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis]Ji-Lin Chen, Yue-Jin Yang, Shu-Bin Qiao, et al.
Chinese Medical Journal|August 25, 2005
The influence of diabetes mellitus on the procedural and in-hospital outcomes after elective percutaneous coronary interventionChong-jian Li, Run-lin Gao, Yue-jin Yang, et al.
Pageof 89

Showing results (751-760 of 888) with videos related to

Sort By:
Pageof 89
Cancer Cell International|November 8, 2023
Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesisPei-Hua Peng, Ji-Lin Chen, Heng-Hsiung Wu, et al.
Chinese Medical Journal|March 28, 2008
Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stentBo Xu, Qi Zhang, Yue-jin Yang, et al.
Chinese Medical Journal|March 28, 2009
Long-term follow-up of crush versus no crush technique for coronary artery bifurcation lesionsZhan Gao, Yue-Jin Yang, Bo Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Phase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced CancerDavid Hong, Jeffrey Infante, Filip Janku, et al.
Chinese Medical Journal|February 4, 2006
Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteriesJi-lin Chen, Run-lin Gao, Yue-jin Yang, et al.
Coronary Artery Disease|October 17, 2008
Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stentJue Chen, Jian-Jun Li, Ji-Lin Chen, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|January 13, 2009
[Outcome of patients implanted with bioabsorbable polymer sirolimus-eluting stent (Excel) and the durable polymer sirolimus-eluting stent (Cypher)]Zhan GAO, Yue-jin YANG, Ji-lin CHEN, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2016
Exoplanet orbital eccentricities derived from LAMOST-Kepler analysisJi-Wei Xie, Subo Dong, Zhaohuan Zhu, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|August 23, 2007
[Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis]Ji-Lin Chen, Yue-Jin Yang, Shu-Bin Qiao, et al.
Chinese Medical Journal|August 25, 2005
The influence of diabetes mellitus on the procedural and in-hospital outcomes after elective percutaneous coronary interventionChong-jian Li, Run-lin Gao, Yue-jin Yang, et al.
Pageof 89